Page last updated: 2024-10-26

diphenyleneiodonium and Leukemia, Myelomonocytic, Acute

diphenyleneiodonium has been researched along with Leukemia, Myelomonocytic, Acute in 1 studies

diphenyleneiodonium: structure in first source; NADPH oxidase inhibitor
dibenziodolium : An organic cation that is fluorene in which the methylene group is replaced by a positively charged iodine.

Leukemia, Myelomonocytic, Acute: A pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. At least 20% of non-erythroid cells are of monocytic origin.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Corcoran, A1
Cotter, TG1

Other Studies

1 other study available for diphenyleneiodonium and Leukemia, Myelomonocytic, Acute

ArticleYear
FLT3-driven redox-modulation of Ezrin regulates leukaemic cell migration.
    Free radical research, 2013, Volume: 47, Issue:1

    Topics: Cell Line; Cell Movement; Cytoskeletal Proteins; fms-Like Tyrosine Kinase 3; HL-60 Cells; Humans; Le

2013